(Q51010186)

27 March 2018

title

Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency. (English)

1 reference

27 March 2018

0 references

6

1 reference

27 March 2018

author name string

S Vuillermot

1

1 reference

27 March 2018

E Joodmardi

2

1 reference

27 March 2018

T Perlmann

3

1 reference

27 March 2018

S Ove Ögren

4

1 reference

27 March 2018

J Feldon

5

1 reference

27 March 2018

language of work or name

English

0 references

publication date

30 May 2011

1 reference

27 March 2018

Genes, Brain and Behavior

published in

1 reference

27 March 2018

volume

10

1 reference

27 March 2018

issue

5

1 reference

27 March 2018

page(s)

589-603

1 reference

27 March 2018

Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Gating and habituation of the startle reflex in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Rodent models of prefrontal cortical function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Nurr1 in Parkinson's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Mouse behavioral assays relevant to the symptoms of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Perseveration in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Maternal vitamin D deficiency alters the expression of genes involved in dopamine specification in the developing rat mesencephalon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

A two-trial memory task with automated recording: study in young and aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Early postnatal isolation reduces dopamine levels, elevates dopamine turnover and specifically disrupts prepulse inhibition in Nurr1-null heterozygous mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Developmental vitamin D deficiency causes abnormal brain development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Negative symptoms in schizophrenia: avolition and Occam's razor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Neurobiology of dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

The dopamine hypothesis of schizophrenia: version III--the final common pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Age-dependent dopaminergic dysfunction in Nurr1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Acoustic startle response, prepulse inhibition, and spontaneous locomotor activity in MPTP-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Neural basis of psychosis-related behaviour in the infection model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Epidemiology-driven neurodevelopmental animal models of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Expression of the CS- and US-pre-exposure effects in the conditioned taste aversion paradigm and their abolition following systemic amphetamine treatment in C57BL6/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Adult mice with reduced Nurr1 expression: an animal model for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Rapid increase of Nurr1 mRNA expression in limbic and cortical brain structures related to coping with depression-like behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

NR4A2 and schizophrenia: lack of association in a Portuguese/Brazilian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

How to make a mesodiencephalic dopaminergic neuron

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Phenotype of schizophrenia: a review and formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Schizophrenia, "just the facts" 4. Clinical features and conceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Distinct forms of prepulse inhibition disruption distinguishable by the associated changes in prepulse-elicited reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

The Effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Dopamine neuron agenesis in Nurr1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-183X.2011.00698.X

10.1111/J.1601-183X.2011.00698.X

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018